Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Tomoka Yonishi

Osaka University Graduate School of Medicine, Osaka (Japan)

19 More presentations in this session

Presentation thumbnail

Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.

Doctor V. Orshanskaya (Saint Petersburg, RU)

Presentation thumbnail

High-normal thyroid-stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation for atrial fibrillation

Doctor I. Morishima (Ogaki, JP)

Presentation thumbnail

Improvement in quality of life in patients that underwent catheter ablation for persistent atrial fibrillation.

Doctor K. Nakajima (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Association of coronary artery disease and revascularization with recurrence of atrial fibrillation after catheter ablation

Doctor D. Hiraya (Tsukuba, JP)

Presentation thumbnail

Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument

Doctor A. Bjorkenheim (Orebro, SE)

Access the full session

Session thumbnail

Poster Session 7 - Atrial fibrillation - Ablation

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Interactive discussion and Q&A

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Session

EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources